CClinicalTrials.gg
Not yet recruitingNCT07066111Updated Jul 15, 2025

The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery

A Phase 4 interventional study of Tramadol and bupivacaine liposome (ultrasound-guided high iliofascial space block) in Postoperative Delirium, sponsored by Nanjing First Hospital, Nanjing Medical University. Not yet recruiting at 1 site in China. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2025-07-15.

Sponsored by Nanjing First Hospital, Nanjing Medical University · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

To explore the effects of bupivacaine liposomes in preemptive analgesia for iliofascial block on postoperative pain and postoperative delirium in elderly patients with hip fractures, to optimize perioperative analgesia strategies, to reduce the incidence of postoperative delirium, and to improve patient prognosis.

Read the detailed description

The incidence of hip fractures has risen significantly with population aging. In 2016, the incidence of hip fractures in China was 177 per 100,000 for women and 99 per 100,000 for men, and it is projected that the number of hip fracture surgeries worldwide will reach 6.3 million by 2050. Surgical treatment is preferred among elderly hip fracture patients, but postoperative delirium (POD) is a common complication, with an incidence rate of 4.0%-53.3%, which is much higher than that of elective surgery patients (3.6%-28.3%). POD is closely associated with increased morbidity, mortality and medical expenses, and its mechanism is complex, involving sleep disorders, acute traumatic stress and inflammatory responses.

Elderly people have underlying diseases such as decreased multi-system functions (for example, organ-specific or chronic diseases) and decreased sensory functions (for example, visual and hearing impairments), and hip fractures can cause pain and functional loss. Pain is A Class A risk factor for POD, and about 42 percent of elderly patients with hip fractures experience moderate to severe pain during the acute phase. Pain not only triggers the release of inflammatory factors but also reduces sleep quality, further increasing the risk of POD. Therefore, effective perioperative analgesia is crucial for reducing the incidence of POD.

Regional nerve block analgesia (such as iliofascial block, FIB) has been widely used in recent years because of its definite analgesic effect and few side effects. Bupivacaine liposomes, as a new type of long-acting local anesthetic, can achieve stable drug release within 72 hours after injection and provide long-acting analgesia, but its effect on POD is not yet clear. This study aims to explore the effect of bupivacaine liposomes on preemptive analgesia of iliofascial block on postoperative pain and POD in elderly patients with hip fractures.

02

Conditions studied

  • Postoperative Delirium

Browse trials for

Keywords

  • preemptive analgesia
  • bupivacaine liposome
  • ip fracture surgery
  • postoperative delirium
03

In context

Emergence Delirium

763 studies on the registry are indexed under Emergence Delirium; 241 are open to participants now.

This study's planned enrollment of 40 is below the median of 120 across 475 interventional studies indexed under Emergence Delirium.

Browse Emergence Delirium studies →

Lead sponsor

Nanjing First Hospital, Nanjing Medical University is the lead sponsor of 213 studies on the registry; 106 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients with hip fractures scheduled for surgical treatment (including femoral neck fractures, intertrochanteric fractures, and fractures more than 5 cm below the lesser trochanter of the femur).
  • Age ≥65 years.
  • American Society of Anesthesiologists (ASA) grade I - III.
  • The patient or family member signed the informed consent form

Exclusion criteria

Exclusion Criteria:

  • Compound injuries (such as combined fractures of the head, chest, pelvis, or limbs).
  • Have a clear history of mental illness or are taking psychotropic drugs.
  • Preoperative delirium or the use of delirium-related medications (such as olanzapine).
  • A history of acute cerebrovascular disease (cerebral infarction or cerebral hemorrhage) within 6 months.
  • Patients requiring sedation or postoperative coma due to the condition.
  • Allergy to amide local anesthetics.
  • Severe arrhythmia or liver or kidney dysfunction
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
40 participants (estimated)

Study arms

  • Placebo comparator
    intramuscularly

    The elderly patients with hip fractures who were randomly divided into the control group were injected tramadol 100mg intramuscularly.

    Drug: Tramadol

  • Experimental
    ultrasound-guided high iliofascial space block

    The elderly patients with hip fractures who were randomly divided into the experimental group were given ultrasound-guided high iliofascial space block

    Drug: bupivacaine liposome (ultrasound-guided high iliofascial space block)

Interventions

  • DrugTramadol

    The control group routinely injected tramadol 100mg(Tramal) intramuscularly

  • Drugbupivacaine liposome (ultrasound-guided high iliofascial space block)

    the experimental group was given ultrasound-guided high iliofascial space block: High-frequency linear probe (5-13 MHZ, Sonosite, USA) was used to identify the iliac bone, iliac muscle and deep circumiliac artery. Then a short oblique puncture needle was used, with the intraplanar technique, and the needle was inserted from the outside. When the needle tip reached the surface of the iliac muscle (iliac fascia space), 20ml of bupivacaine liposome was injected. After the operation, electrocardiogram monitoring(Mindray) was performed for 1 hour to observe adverse reactions.

06

What researchers measure

Primary outcomes

  1. POD incidence

    Evaluated via the CAM scale. * CAM diagnostic criteria: 1. Acute onset of mental changes and fluctuating course of the disease. 2. Inattentiveness. 3. Disordered thinking. 4. Changes in consciousness levels. * A POD is diagnosed if it meets 1+2 or 1+3 or 1+4.

    Time frame: Evaluated twice daily within 3 days after surgery (8:00-10:00 and 18:00-20:00)

Secondary outcomes

  1. Preoperative pain

    Evaluate rest and exercise pain via VAS score (0-10)and record the consumption of analgesics.The higher the VAS score, the more severe the pain will be.

    Time frame: before the surgery.

  2. Postoperative pain

    Evaluate rest and exercise pain via VAS score (0-10).

    Time frame: twice a day for 1-3 days after the operation

  3. Number of participants with Sleep quality

    Sleep quality monitored by Cardiopulmonary coupling instrument.The cardiopulmonary coupling (CPC) technology utilizes heart rate variability to measure the function of the autonomic nervous system, and combines it with the extracted respiratory signals from the electrocardiogram (ECG) to generate a sleep profile. Using the CPC device, data such as single-lead ECG signals, sleep duration, respiratory events, activity level, and body position of the patients during sleep are monitored for data analysis to evaluate their sleep conditions.

    Time frame: from hospitalization to 3 days after surgery(22:30-06:30).

  4. Recovery quality

    Evaluated by QoR-15 score.QoR-15 was used to assess five aspects of postoperative recovery quality (physical comfort, physical independence, psychological support, emotion and pain), with higher scores indicating the higher postoperative recovery quality. The lowest score is 0 points, and the highest score is 150 points.

    Time frame: 24 hours after surgery

  5. Anesthesia method form

    Anesthesia method of the surgery

    Time frame: during operation

  6. intraoperative medication checklist

    intraoperative medication of the surgery

    Time frame: during operation

  7. Number of participants with hemodynamic changes

    hemodynamic changes during the operation.The changes in blood pressure, heart rate, blood oxygen saturation,body temperature and EtCO2 of the patients during the surgery were recorded through the monitoring equipment provided by Mindray.

    Time frame: during the operation

  8. postoperative complications

    postoperative complications after the surgery

    Time frame: Periprocedural

  9. length of hospital stay

    length of hospital stay

    Time frame: Periprocedural

  10. 30-day mortality

    30-day mortality

    Time frame: 30-day after surgery

07

Study locations

1 site
  • Nanjing First Hospital
    Nanjing, Jiangsu 210006, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07066111
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Responsible party
Hongwei Shi (Director, Department of Anesthesia, Pain and Perioperative Medicine, Nanjing First Hospital, Nanjing Medical University) — Principal investigator
First posted
Jul 15, 2025
Start date
Jul 20, 2025 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Jul 15, 2025

Study contacts

Liu Han
Contact
han_cold.student@sina.com
18951670163

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion